CN Stock MarketDetailed Quotes

688336 Sunshine Guojian Pharmaceutical

Watchlist
  • 22.71
  • +0.87+3.98%
Market Closed Jun 17 15:00 CST
14.01BMarket Cap39.77P/E (TTM)

Sunshine Guojian Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
28.72%266.9M
22.84%1.01B
38.54%730.6M
40.28%477.81M
29.17%207.34M
-11.12%825.49M
-16.03%527.35M
-28.85%340.6M
3.34%160.51M
41.80%928.81M
Operating revenue
28.72%266.9M
22.84%1.01B
38.54%730.6M
40.28%477.81M
29.17%207.34M
-11.12%825.49M
-16.03%527.35M
-28.85%340.6M
3.34%160.51M
41.80%928.81M
Total operating cost
-5.73%169.63M
-4.84%791.66M
-0.93%573.32M
2.99%395.82M
2.49%179.93M
-17.91%831.92M
-18.19%578.72M
-24.60%384.34M
-18.74%175.56M
11.71%1.01B
Operating cost
7.21%61.18M
11.38%224.1M
23.57%168.23M
36.38%119.13M
39.14%57.07M
-4.20%201.2M
0.12%136.14M
-12.65%87.35M
53.05%41.01M
105.32%210.02M
Operating tax surcharges
11.02%2.14M
50.47%9.37M
83.25%6.84M
55.00%4.6M
-1.93%1.93M
51.53%6.23M
64.05%3.73M
75.77%2.96M
237.77%1.97M
26.93%4.11M
Operating expense
-4.05%51.39M
0.54%251.79M
10.45%194.87M
7.03%126.18M
5.64%53.55M
-5.59%250.45M
-7.47%176.43M
-23.18%117.89M
-34.52%50.7M
-28.63%265.28M
Administration expense
17.97%16.92M
-23.72%63.1M
-21.24%52.13M
-22.76%34.58M
-40.63%14.34M
-18.79%82.73M
-15.23%66.18M
-14.30%44.77M
9.25%24.16M
3.19%101.87M
Financial expense
-114.85%-15.17M
-77.56%-39.01M
-39.57%-28.39M
-20.89%-18.38M
-9.66%-7.06M
4.34%-21.97M
-16.94%-20.34M
-31.43%-15.2M
11.42%-6.44M
-154.79%-22.97M
-Interest expense (Financial expense)
-39.23%302.8K
6.54%1.4M
146.81%1.1M
--782.85K
--498.3K
--1.32M
--444.03K
----
----
----
-Interest Income (Financial expense)
-85.03%-14.94M
-98.16%-39.64M
-62.52%-27.76M
-34.34%-16.86M
-25.96%-8.08M
16.44%-20M
0.26%-17.08M
-8.56%-12.55M
-2.52%-6.41M
-63.75%-23.94M
Research and development
-11.55%53.16M
-9.89%282.3M
-17.05%179.65M
-11.50%129.71M
-6.33%60.1M
-31.16%313.28M
-31.85%216.58M
-31.48%146.56M
-33.44%64.16M
33.75%455.09M
Credit Impairment Loss
-347.08%-389.9K
223.83%6.8M
213.52%6.82M
209.10%6.63M
-68.58%157.8K
-345.19%-5.49M
-455.81%-6M
-164.17%-6.08M
-7.84%502.31K
-129.04%-1.23M
Asset Impairment Loss
-105.45%-72K
129.44%1.06M
88.04%-456.26K
90.54%-396.1K
253.70%1.32M
---3.61M
---3.81M
---4.19M
---860.14K
----
Other net revenue
Fair value change income
11.33%5.41M
-45.29%19.4M
-44.75%13.74M
-30.10%9.65M
-15.03%4.86M
46.49%35.46M
33.55%24.88M
12.31%13.81M
-12.33%5.72M
-12.57%24.2M
Invest income
8.30%-3.44M
-5.93%-16.4M
-33,929.59%-12.81M
-22,590.74%-8.54M
---3.75M
-372.27%-15.48M
-101.83%-37.66K
-101.83%-37.66K
----
66.12%-3.28M
-Including: Investment income associates
8.30%-3.44M
-5.93%-16.4M
-33,929.59%-12.81M
-22,590.74%-8.54M
---3.75M
-372.27%-15.48M
-101.83%-37.66K
-101.83%-37.66K
----
66.12%-3.28M
Asset deal income
----
6,068.23%56.39M
-81.84%-1.42M
-828.94%-1.38M
-157.39%-333.9K
92.72%-944.86K
28.19%-782.4K
70.82%-148.55K
72.11%-129.73K
-2,658.46%-12.98M
Other revenue
55.17%5.09M
-14.55%28.58M
-48.76%11.27M
-58.37%7.27M
-29.59%3.28M
-2.37%33.45M
34.17%22M
58.41%17.46M
-15.35%4.66M
-20.92%34.26M
Operating profit
215.32%103.87M
761.35%318.21M
1,253.09%174.42M
515.53%95.22M
738.37%32.94M
184.68%36.94M
65.99%-15.13M
-172.02%-22.92M
89.59%-5.16M
78.52%-43.63M
Less:Non operating expense
200.04%4M
-5.11%7.58M
-2.93%5.16M
-51.19%1.71M
-43.66%1.33M
-18.13%7.99M
13.96%5.32M
2.89%3.5M
-10.05%2.37M
-88.18%9.76M
Total profit
215.96%99.87M
972.79%310.63M
927.95%169.26M
454.06%93.52M
519.92%31.61M
154.24%28.96M
58.40%-20.44M
-123.40%-26.41M
85.58%-7.53M
81.10%-53.39M
Less:Income tax cost
988.64%11.11M
265.51%27.27M
199.39%14.36M
132.75%4.36M
120.70%1.02M
68.12%-16.48M
62.56%-14.45M
43.97%-13.31M
69.45%-4.93M
-10.94%-51.69M
Net profit
190.20%88.76M
523.67%283.36M
FLtoP154.9M
FLtoP89.16M
FLtoP30.59M
FLtoP45.43M
FPtoL-6M
SL-13.1M
FPtoL-2.6M
FPtoL-1.7M
Net profit from continuing operation
190.20%88.76M
523.67%283.36M
2,683.45%154.9M
780.47%89.16M
1,277.08%30.59M
2,778.75%45.43M
43.17%-6M
-209.79%-13.1M
92.79%-2.6M
99.28%-1.7M
Less:Minority Profit
19.47%-2.36M
-191.35%-11.25M
-25.69%-9.02M
5.34%-5.6M
0.67%-2.93M
80.45%-3.86M
55.90%-7.17M
43.63%-5.91M
37.63%-2.95M
-7.64%-19.75M
Net profit of parent company owners
171.88%91.12M
497.63%294.61M
13,826.23%163.92M
1,417.98%94.75M
9,494.38%33.51M
172.99%49.3M
-79.40%1.18M
-132.06%-7.19M
101.12%349.32K
108.30%18.06M
Earning per share
Basic earning per share
200.00%0.15
500.00%0.48
--0.27
1,600.00%0.15
--0.05
166.67%0.08
--0
-125.00%-0.01
--0
108.11%0.03
Diluted earning per share
200.00%0.15
500.00%0.48
--0.27
1,600.00%0.15
--0.05
166.67%0.08
--0
-125.00%-0.01
--0
108.11%0.03
Other composite income
127.94%930K
-70.63%1.96M
-67.18%4.55M
14.67%5.14M
29.60%-3.33M
187.11%6.66M
855.82%13.86M
259.76%4.48M
-824.94%-4.73M
26.20%-7.65M
Other composite income of parent company owners
127.94%930K
-70.63%1.96M
-67.18%4.55M
14.67%5.14M
29.60%-3.33M
187.11%6.66M
855.82%13.86M
259.76%4.48M
-824.94%-4.73M
26.20%-7.65M
Add:Adjusted items effecting composite income
--100
----
----
----
----
----
----
----
----
----
Total composite income
229.05%89.69M
447.69%285.32M
1,928.67%159.45M
1,193.50%94.29M
472.02%27.26M
657.63%52.09M
186.36%7.86M
-165.43%-8.62M
79.30%-7.33M
96.21%-9.34M
Total composite income of parent company owners
204.94%92.05M
429.99%296.57M
1,020.65%168.46M
3,785.79%99.89M
789.32%30.19M
437.41%55.96M
109.82%15.03M
-111.45%-2.71M
85.72%-4.38M
104.57%10.41M
Total composite income of minority owners
19.47%-2.36M
-191.35%-11.25M
-25.69%-9.02M
5.34%-5.6M
0.67%-2.93M
80.45%-3.86M
55.90%-7.17M
43.63%-5.91M
37.63%-2.95M
-7.64%-19.75M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
--
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 28.72%266.9M22.84%1.01B38.54%730.6M40.28%477.81M29.17%207.34M-11.12%825.49M-16.03%527.35M-28.85%340.6M3.34%160.51M41.80%928.81M
Operating revenue 28.72%266.9M22.84%1.01B38.54%730.6M40.28%477.81M29.17%207.34M-11.12%825.49M-16.03%527.35M-28.85%340.6M3.34%160.51M41.80%928.81M
Total operating cost -5.73%169.63M-4.84%791.66M-0.93%573.32M2.99%395.82M2.49%179.93M-17.91%831.92M-18.19%578.72M-24.60%384.34M-18.74%175.56M11.71%1.01B
Operating cost 7.21%61.18M11.38%224.1M23.57%168.23M36.38%119.13M39.14%57.07M-4.20%201.2M0.12%136.14M-12.65%87.35M53.05%41.01M105.32%210.02M
Operating tax surcharges 11.02%2.14M50.47%9.37M83.25%6.84M55.00%4.6M-1.93%1.93M51.53%6.23M64.05%3.73M75.77%2.96M237.77%1.97M26.93%4.11M
Operating expense -4.05%51.39M0.54%251.79M10.45%194.87M7.03%126.18M5.64%53.55M-5.59%250.45M-7.47%176.43M-23.18%117.89M-34.52%50.7M-28.63%265.28M
Administration expense 17.97%16.92M-23.72%63.1M-21.24%52.13M-22.76%34.58M-40.63%14.34M-18.79%82.73M-15.23%66.18M-14.30%44.77M9.25%24.16M3.19%101.87M
Financial expense -114.85%-15.17M-77.56%-39.01M-39.57%-28.39M-20.89%-18.38M-9.66%-7.06M4.34%-21.97M-16.94%-20.34M-31.43%-15.2M11.42%-6.44M-154.79%-22.97M
-Interest expense (Financial expense) -39.23%302.8K6.54%1.4M146.81%1.1M--782.85K--498.3K--1.32M--444.03K------------
-Interest Income (Financial expense) -85.03%-14.94M-98.16%-39.64M-62.52%-27.76M-34.34%-16.86M-25.96%-8.08M16.44%-20M0.26%-17.08M-8.56%-12.55M-2.52%-6.41M-63.75%-23.94M
Research and development -11.55%53.16M-9.89%282.3M-17.05%179.65M-11.50%129.71M-6.33%60.1M-31.16%313.28M-31.85%216.58M-31.48%146.56M-33.44%64.16M33.75%455.09M
Credit Impairment Loss -347.08%-389.9K223.83%6.8M213.52%6.82M209.10%6.63M-68.58%157.8K-345.19%-5.49M-455.81%-6M-164.17%-6.08M-7.84%502.31K-129.04%-1.23M
Asset Impairment Loss -105.45%-72K129.44%1.06M88.04%-456.26K90.54%-396.1K253.70%1.32M---3.61M---3.81M---4.19M---860.14K----
Other net revenue
Fair value change income 11.33%5.41M-45.29%19.4M-44.75%13.74M-30.10%9.65M-15.03%4.86M46.49%35.46M33.55%24.88M12.31%13.81M-12.33%5.72M-12.57%24.2M
Invest income 8.30%-3.44M-5.93%-16.4M-33,929.59%-12.81M-22,590.74%-8.54M---3.75M-372.27%-15.48M-101.83%-37.66K-101.83%-37.66K----66.12%-3.28M
-Including: Investment income associates 8.30%-3.44M-5.93%-16.4M-33,929.59%-12.81M-22,590.74%-8.54M---3.75M-372.27%-15.48M-101.83%-37.66K-101.83%-37.66K----66.12%-3.28M
Asset deal income ----6,068.23%56.39M-81.84%-1.42M-828.94%-1.38M-157.39%-333.9K92.72%-944.86K28.19%-782.4K70.82%-148.55K72.11%-129.73K-2,658.46%-12.98M
Other revenue 55.17%5.09M-14.55%28.58M-48.76%11.27M-58.37%7.27M-29.59%3.28M-2.37%33.45M34.17%22M58.41%17.46M-15.35%4.66M-20.92%34.26M
Operating profit 215.32%103.87M761.35%318.21M1,253.09%174.42M515.53%95.22M738.37%32.94M184.68%36.94M65.99%-15.13M-172.02%-22.92M89.59%-5.16M78.52%-43.63M
Less:Non operating expense 200.04%4M-5.11%7.58M-2.93%5.16M-51.19%1.71M-43.66%1.33M-18.13%7.99M13.96%5.32M2.89%3.5M-10.05%2.37M-88.18%9.76M
Total profit 215.96%99.87M972.79%310.63M927.95%169.26M454.06%93.52M519.92%31.61M154.24%28.96M58.40%-20.44M-123.40%-26.41M85.58%-7.53M81.10%-53.39M
Less:Income tax cost 988.64%11.11M265.51%27.27M199.39%14.36M132.75%4.36M120.70%1.02M68.12%-16.48M62.56%-14.45M43.97%-13.31M69.45%-4.93M-10.94%-51.69M
Net profit 190.20%88.76M523.67%283.36MFLtoP154.9MFLtoP89.16MFLtoP30.59MFLtoP45.43MFPtoL-6MSL-13.1MFPtoL-2.6MFPtoL-1.7M
Net profit from continuing operation 190.20%88.76M523.67%283.36M2,683.45%154.9M780.47%89.16M1,277.08%30.59M2,778.75%45.43M43.17%-6M-209.79%-13.1M92.79%-2.6M99.28%-1.7M
Less:Minority Profit 19.47%-2.36M-191.35%-11.25M-25.69%-9.02M5.34%-5.6M0.67%-2.93M80.45%-3.86M55.90%-7.17M43.63%-5.91M37.63%-2.95M-7.64%-19.75M
Net profit of parent company owners 171.88%91.12M497.63%294.61M13,826.23%163.92M1,417.98%94.75M9,494.38%33.51M172.99%49.3M-79.40%1.18M-132.06%-7.19M101.12%349.32K108.30%18.06M
Earning per share
Basic earning per share 200.00%0.15500.00%0.48--0.271,600.00%0.15--0.05166.67%0.08--0-125.00%-0.01--0108.11%0.03
Diluted earning per share 200.00%0.15500.00%0.48--0.271,600.00%0.15--0.05166.67%0.08--0-125.00%-0.01--0108.11%0.03
Other composite income 127.94%930K-70.63%1.96M-67.18%4.55M14.67%5.14M29.60%-3.33M187.11%6.66M855.82%13.86M259.76%4.48M-824.94%-4.73M26.20%-7.65M
Other composite income of parent company owners 127.94%930K-70.63%1.96M-67.18%4.55M14.67%5.14M29.60%-3.33M187.11%6.66M855.82%13.86M259.76%4.48M-824.94%-4.73M26.20%-7.65M
Add:Adjusted items effecting composite income --100------------------------------------
Total composite income 229.05%89.69M447.69%285.32M1,928.67%159.45M1,193.50%94.29M472.02%27.26M657.63%52.09M186.36%7.86M-165.43%-8.62M79.30%-7.33M96.21%-9.34M
Total composite income of parent company owners 204.94%92.05M429.99%296.57M1,020.65%168.46M3,785.79%99.89M789.32%30.19M437.41%55.96M109.82%15.03M-111.45%-2.71M85.72%-4.38M104.57%10.41M
Total composite income of minority owners 19.47%-2.36M-191.35%-11.25M-25.69%-9.02M5.34%-5.6M0.67%-2.93M80.45%-3.86M55.90%-7.17M43.63%-5.91M37.63%-2.95M-7.64%-19.75M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----------Unqualified opinion--------
Auditor ----------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg